Literature DB >> 6162546

Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs.

C K Mirabelli, C H Huang, S T Crooke.   

Abstract

Single- and double-strand breakage of isolated PM-2 DNA by structural analogs of the glycopeptide antitumor antibiotics bleomycin (BLM) and talisomycin (TLM) was investigated. Breakage of PM-2 DNA was determined by two systems: an ethidium bromide fluorescence assay; and agarose gel electrophoresis. The fluorescence assay, which measures total breakage of DNA including single- and double-strand breakage and alkaline labile damage, showed that the BLM's, A2 and B2 induced more total DNA breakage than did the TLM's A, B, S2b, and S10b. As measured by the comparison of the concentration of analog required to cause 50% breakage of superhelical DNA, BLM's A2 and B2 were 10 times more active than TLM's S2b and S10b and 25 times more active than TLM's A and B. Gel electrophoresis, which measures the extent of both single- and double-strand breakage of DNA, showed that at equivalent levels of breakage of superhelical DNA each of the TLM's caused more double-strand breakage of DNA than did the BLM's. Thus, the structural alterations near the bithiazole in the TLM's, which distinguish them structurally from the BLM's, result in a reduction of the total PM-2 DNA breakage activity and enhanced production of double-strand breaks relative to single-strand breaks by TLM when compared to BLM.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6162546

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  The large terminase DNA packaging motor grips DNA with its ATPase domain for cleavage by the flexible nuclease domain.

Authors:  Brendan J Hilbert; Janelle A Hayes; Nicholas P Stone; Rui-Gang Xu; Brian A Kelch
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

2.  Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin.

Authors:  C K Mirabelli; C H Huang; R G Fenwick; S T Crooke
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

3.  Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.

Authors:  C K Mirabelli; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.

Authors:  C K Mirabelli; C H Huang; A W Prestayko; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  X-ray crystallographic analysis of 3-(2'-phenyl-2,4'-bithiazole-4-carboxamido) propyldimethylsulphonium iodide, an analogue of the DNA-binding portion of bleomycin A2.

Authors:  R Kuroda; S Neidle; J M Riordan; T T Sakai
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

6.  Improved genetically modified Escherichia coli strain for prescreening antineoplastic agents.

Authors:  H R Bartus; C K Mirabelli; J I Auerbach; A R Shatzman; D P Taylor; R K Johnson; M Rosenberg; S T Crooke
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.